The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Invasive fungal disease in humans: are we aware of the real impact?
Open accessAbstract
Despite the medical advances and interventions to improve the quality of life of those in intensive care, people with cancer or severely immunocompromised or other susceptible hosts, invasive fungal diseases (IFD) remain severe and underappreciated causes of illness and death worldwide. Therefore, IFD continue to be a public health threat and a major hindrance to the success of otherwise life-saving treatments and procedures. Globally, hundreds of thousands of people are affected every year with Candida albicans, Aspergillus fumigatus, Cryptococcus neoformans, Pneumocystis jirovecii, endemic dimorphic fungi and Mucormycetes, the most common fungal species causing invasive diseases in humans. These infections result in morbidity and mortality rates that are unacceptable and represent a considerable socioeconomic burden. Raising the general awareness of the significance and impact of IFD in human health, in both the hospital and the community, is hence critical to understand the scale of the problem and to raise interest to help fighting these devastating diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The trinity of COVID-19: immunity, inflammation and intervention
Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0311-8 · Cited by 4,360
Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision
Bongomin, F., Gago, S., Oladele, R., & Denning, D. (2017) · Journal of Fungi · doi:10.3390/jof3040057 · Cited by 2,953 · cited 10×
“Disseminated histoplasmosis Histoplasma capsulatum ~ 100,000(6) 10 -60(42)”
BackgroundInfluentialGlobal burden of disease of HIV-associated cryptococcal meningitis: an updated analysis
Rajasingham, R., Smith, R. M., Park, B. J., Jarvis, J. N., Govender, N. P., Chiller, T. M., Denning, D. W., Loyse, A., & Boulware, D. R. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30243-8 · Cited by 1,861
Neofytos, D., Horn, D., Anaissie, E., Steinbach, W., Olyaei, A., Fishman, J., Pfaller, M., Chang, C., Webster, K., & Marr, K. (2009) · Clinical Infectious Diseases · doi:10.1086/595846 · Cited by 801
Nosocomial fungal infections: epidemiology, diagnosis, and treatment
Perlroth, J., Choi, B., & Spellberg, B. (2007) · Medical Mycology · doi:10.1080/13693780701218689 · Cited by 738 · cited 3×
“(15) Directly related with medical interventions, nosocomial candidaemia is associated with prolonged stays in hospital and intensive care units, parenteral nutrition, as well as with improved survival of premature infants.(11) Despite the broad use of antifungal prophylaxis, mostly fluconazole, which has shown to red…”
BackgroundCandida Biofilms: Threats, Challenges, and Promising Strategies
Cavalheiro, M., & Teixeira, M. C. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00028 · Cited by 690 · cited 1×
“Biofilms are a physical barrier intrinsically resistant to the host immune system and other environmental perturbations.(14) The formation of biofilms additionally leads to upregulation of antifungal-resistance mechanisms, as well as the development of complex regulatory processes that favour even higher levels of ant…”
BackgroundRamage, G., Rajendran, R., Sherry, L., & Williams, C. (2012) · International Journal of Microbiology · doi:10.1155/2012/528521 · Cited by 583 · cited 1×
“(14) The formation of biofilms additionally leads to upregulation of antifungal-resistance mechanisms, as well as the development of complex regulatory processes that favour even higher levels of antifungal resistance, most notably to azoles and polyenes.(15) Directly related with medical interventions, nosocomial can…”
BackgroundJarvis, J. N., Bicanic, T., Loyse, A., Namarika, D., Jackson, A., Nussbaum, J. C., Longley, N., Muzoora, C., Phulusa, J., Taseera, K., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit794 · Cited by 367
Pneumocystis Pneumonia: Current Concepts in Pathogenesis, Diagnosis, and Treatment
Krajicek, B. J., Thomas, C. F., & Limper, A. H. (2009) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2009.02.005 · Cited by 73
Cited by
Hodges, M. R., Ople, E., Wedel, P., Shaw, K. J., Jakate, A., Kramer, W. G., Marle, S. V., van Hoogdalem, E.-J., & Tawadrous, M. (2023) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01623-22 · Cited by 52
Antifungal Activity of Minocycline and Azoles Against Fluconazole-Resistant Candida Species
Tan, J., Jiang, S., Tan, L., Shi, H., Yang, L., Sun, Y., & Wang, X. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.649026 · Cited by 28
Lv, Q., Yan, L., Wang, J., Feng, J., Gao, L., Qiu, L., Chao, W., Qin, Y.-L., & Jiang, Y. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03209-22 · Cited by 12
“which is comparable to the number of deaths caused by tuberculosis (3).”
Background
Metadata
- Authors
- Firacative, C.
- Venue
- Memórias do Instituto Oswaldo Cruz
- Publisher
- FapUNIFESP (SciELO)
- Published
- 2020
- Volume
- 115
- Pages
- e200430-e200430
- ISSN
- 0074-0276 (ISSN-L)
- 1678-8060
- OpenAlex
- W3092750903
- Cited by
- 184
- References
- 9
- FWCI
- 3.29
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Invasive fungal disease in humans: are we aware of the real impact? https://app.cochat.ai/papers/10.1590/0074-02760200430
- The paper
- Firacative, C. (2020). Invasive fungal disease in humans: are we aware of the real impact? Memórias do Instituto Oswaldo Cruz. https://doi.org/10.1590/0074-02760200430
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.